159 related articles for article (PubMed ID: 36405738)
1. Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer.
Li L; Wang J; Zhang Z; Yang Q; Deng Z; Zou W; Ge X; Pan K; Li C; Liu R
Front Immunol; 2022; 13():1052768. PubMed ID: 36405738
[TBL] [Abstract][Full Text] [Related]
2. CKS1B as a potential target for prognostic assessment and intervention in pancreatic cancer and its role in abnormal proliferation and cellular phenotype through mediation of cell cycle signaling pathways.
Tang Y; Lan X; Yan M; Fu Z; Li H
Saudi Med J; 2024 Feb; 45(2):128-138. PubMed ID: 38309745
[TBL] [Abstract][Full Text] [Related]
3. A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Jia Y; Tian Q; Yang K; Liu Y; Liu Y
Biomed Res Int; 2021; 2021():5862941. PubMed ID: 34845438
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway.
Zeng Z; Gao ZL; Zhang ZP; Jiang HB; Yang CQ; Yang J; Xia XB
Int J Mol Med; 2019 Jul; 44(1):103-114. PubMed ID: 31115482
[TBL] [Abstract][Full Text] [Related]
5. CKS1B promotes cell proliferation and invasion by activating STAT3/PD-L1 and phosphorylation of Akt signaling in papillary thyroid carcinoma.
Wang H; Zhang Z; Yan Z; Ma S
J Clin Lab Anal; 2021 Jan; 35(1):e23565. PubMed ID: 32960462
[TBL] [Abstract][Full Text] [Related]
6. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma.
Lee SW; Lin CY; Tian YF; Sun DP; Lin LC; Chen LT; Hsing CH; Huang CT; Hsu HP; Huang HY; Wu LC; Li CF; Shiue YL
APMIS; 2014 Mar; 122(3):206-14. PubMed ID: 23879533
[TBL] [Abstract][Full Text] [Related]
8. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR-520h/CKS1B axis.
Li P; Wang H; Tang Y; Sun S; Ma Y; Xu Y; Chen G
Exp Ther Med; 2021 Oct; 22(4):1142. PubMed ID: 34504588
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis.
Wang X; Tao G; Huang D; Liang S; Zheng D
Oncol Rep; 2020 Nov; 44(5):2009-2020. PubMed ID: 32901890
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
Li J; Yin L; Chen Y; An S; Xiong Y; Huang G; Liu J
Int J Med Sci; 2021; 18(14):3150-3157. PubMed ID: 34400885
[No Abstract] [Full Text] [Related]
12. MicroRNA-1258 Inhibits the Proliferation and Migration of Human Colorectal Cancer Cells through Suppressing CKS1B Expression.
Hwang JS; Jeong EJ; Choi J; Lee YJ; Jung E; Kim SK; Min JK; Han TS; Kim JS
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31717435
[TBL] [Abstract][Full Text] [Related]
13. Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.
Deng T; Liu Y; Yang Y; Yuan L; Liu F; Wang X; Zhang Q; Xie M
Bioengineered; 2022 Mar; 13(3):4757-4772. PubMed ID: 35174774
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma.
Shaughnessy J
Hematology; 2005; 10 Suppl 1():117-26. PubMed ID: 16188652
[TBL] [Abstract][Full Text] [Related]
15. Loss of miR-1258 contributes to carcinogenesis and progression of liver cancer through targeting CDC28 protein kinase regulatory subunit 1B.
Hu M; Wang M; Lu H; Wang X; Fang X; Wang J; Ma C; Chen X; Xia H
Oncotarget; 2016 Jul; 7(28):43419-43431. PubMed ID: 27270326
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.
Shi L; Wang S; Zangari M; Xu H; Cao TM; Xu C; Wu Y; Xiao F; Liu Y; Yang Y; Salama M; Li G; Tricot G; Zhan F
Oncotarget; 2010 May; 1(1):22-33. PubMed ID: 20930946
[TBL] [Abstract][Full Text] [Related]
17. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
[TBL] [Abstract][Full Text] [Related]
19. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
Zhan F; Colla S; Wu X; Chen B; Stewart JP; Kuehl WM; Barlogie B; Shaughnessy JD
Blood; 2007 Jun; 109(11):4995-5001. PubMed ID: 17303695
[TBL] [Abstract][Full Text] [Related]
20. 3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways.
Wang H; Sun M; Guo J; Ma L; Jiang H; Gu L; Wen H; Liao S; Chen J; Zeng B; Li Y; Li Y; Yu X; Feng Y; Zhou Y
Biochem Pharmacol; 2017 Jul; 135():35-49. PubMed ID: 28288818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]